The Division of Biological Chemistry publishes its newsletter on an annual schedule. Hear the latest news from our Chair, and read about upcoming meetings and symposia, award nominations, officer elections, and travel grants.

Message from the Chair: Anne-Frances Miller, Ph.D.

Dear Members of the Division of Biological Chemistry,

To our younger members:


You are right to be seriously concerned, these are hard times. However please know that we’re glad you are with us. It will be small comfort to hear me say that ‘we’ve been here before’, nonetheless it is true that there are some potent lessons to be learned from past contractions. Circumstances may dictate what we do, but we retain agency as to how we do so. A race to the bottom is a dangerous and short-sighted one to win. We can all use this time to examine our long-term visions for our profession and society, as well as our selves.

Researchers responding to Coronavirus to speak to our division

We will have to wait until the end of May to learn the ACS’ format for the National meeting in August. However, the division has already lined up excellent speakers. Among them are some of the biochemists making decisive progress against Covid-19. The Bader award winner, Kevan Schokat, is screening SARS-CoV-2 proteins and the human proteins they interact with, to identify targets that could be addressed using already-approved drugs. The keynote speaker of the ACS – infectious diseases symposium will be Richard Mackman, one of the inventors of remdesivir. This is one of the drugs with some promise against Covid-19. In the “RNA-based therapies and therapeutics” session, Moderna’s chief scientific officer, Melissa Moore will speak. Moderna is developing an mRNA-based vaccine against Covid-19.

For more information, please see the newsletter below!

Anne-Frances Miller

Please email to afmill3r2@gmail.com and include ‘DBC’ in the subject line to help me retrieve your message from the sea of stuff.

Sign up for our Newsletter

 

Newsletter Archive